730 related articles for article (PubMed ID: 26057769)
1. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
Md S; Mustafa G; Baboota S; Ali J
Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
[TBL] [Abstract][Full Text] [Related]
2. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
3. Insights into direct nose to brain delivery: current status and future perspective.
Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery.
Battaglia L; Panciani PP; Muntoni E; Capucchio MT; Biasibetti E; De Bonis P; Mioletti S; Fontanella M; Swaminathan S
Expert Opin Drug Deliv; 2018 Apr; 15(4):369-378. PubMed ID: 29338427
[TBL] [Abstract][Full Text] [Related]
5. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
Selvaraj K; Gowthamarajan K; Karri VVSR
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
[TBL] [Abstract][Full Text] [Related]
6. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
Kashyap K; Shukla R
Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
[TBL] [Abstract][Full Text] [Related]
7. Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review.
Babu SR; Shekara HH; Sahoo AK; Harsha Vardhan PV; Thiruppathi N; Venkatesh MP
Ther Deliv; 2023 Sep; 14(9):571-594. PubMed ID: 37691577
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles for direct nose-to-brain delivery of drugs.
Mistry A; Stolnik S; Illum L
Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
[TBL] [Abstract][Full Text] [Related]
9. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
Pardeshi CV; Belgamwar VS
Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
11. Drug delivery systems from nose to brain.
Misra A; Kher G
Curr Pharm Biotechnol; 2012 Sep; 13(12):2355-79. PubMed ID: 23016642
[TBL] [Abstract][Full Text] [Related]
12. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
[TBL] [Abstract][Full Text] [Related]
13. Nanosized Drug Delivery Systems for Direct Nose to Brain Targeting: A Review.
Phukan K; Nandy M; Sharma RB; Sharma HK
Recent Pat Drug Deliv Formul; 2016; 10(2):156-64. PubMed ID: 26996366
[TBL] [Abstract][Full Text] [Related]
14. Nose-to-Brain Delivery: Investigation of the Transport of Nanoparticles with Different Surface Characteristics and Sizes in Excised Porcine Olfactory Epithelium.
Mistry A; Stolnik S; Illum L
Mol Pharm; 2015 Aug; 12(8):2755-66. PubMed ID: 25997083
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review.
Kulkarni AD; Vanjari YH; Sancheti KH; Belgamwar VS; Surana SJ; Pardeshi CV
J Drug Target; 2015; 23(9):775-88. PubMed ID: 25758751
[TBL] [Abstract][Full Text] [Related]
16. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
[TBL] [Abstract][Full Text] [Related]
17. [Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia].
Kamei N
Yakugaku Zasshi; 2017; 137(10):1247-1253. PubMed ID: 28966266
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
19. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
[TBL] [Abstract][Full Text] [Related]
20. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
Gao H
J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
